Q32 Bio Inc. (QTTB) Operating Expenses (2017 - 2026)

Q32 Bio has reported Operating Expenses for 10 years, with the latest figure at $9.1 million in Q2 2026.

• On a quarterly basis, Operating Expenses fell 0.58% year-over-year to $9.1 million in Q2 2026; TTM through Jun 2026 was $32.3 million, a 41.04% decrease from a year earlier, with the FY2025 full-year figure at $36.8 million, down 44.28% from the prior year.
• Operating Expenses was $9.1 million for Q2 2026 at Q32 Bio, up from $7.7 million in the prior quarter.
• The five-year high for Operating Expenses was $38.4 million in Q1 2022, with the low at $7.6 million in Q3 2025.
• Average Operating Expenses over 5 years is $16.5 million, with a median of $11.7 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses plunged 73.14% in 2023, then soared 94.82% in 2024.
• Over 5 years, Operating Expenses stood at $35.3 million in 2022, then plunged by 68.42% to $11.1 million in 2023, then soared by 30.31% to $14.5 million in 2024, then slumped by 45.9% to $7.9 million in 2025, then advanced by 16.03% to $9.1 million in 2026.
• The last three Operating Expenses figures came in at $9.1 million (Q2 2026), $7.7 million (Q1 2026), and $7.9 million (Q4 2025), per Business Quant data.